ПРОФИЛАКТИКА ИНФЕКЦИОННО-ВОСПАЛИТЕЛЬНЫХ ОСЛОЖНЕНИЙ В ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ У БОЛЬНЫХ ПОСЛЕ ФАКОЭМУЛЬСИФИКАЦИИ КАТАРАКТЫ

П. А. Бездетко; О. В. Заволока

doi:10.31288/oftalmolzh201312426

PREVENTION OF THE INFECTIONS-INFLAMMATORY COMLICATIONS IN POSTOPERATIONAL PERIOD IN PATIENTS AFTER CATARACT PHACOEMUSIFICATION.

Authors

P. A. Bezdetko Kharkov, Ukraine
O. V. Zavoloka Kharkov, Ukraine

DOI:

https://doi.org/10.31288/oftalmolzh201312426

Keywords:

neladex, cataract phacoemilsification, postoperation period, infectionus-inflammatory complication

Abstract

Neladex was used in 30 patients after cataract phacoemulsificataion in postoperational period 4—6 times per day. Examination was made on the 1st day, 7th day, 14th day, and 1st month after surgery. Eye drops «Neladex» was effective for prevention of the infectious-inflammatory complication in eye surgery, that is why we recommend them for general usage in ophthalmological practice.

References

1.Егоров Е. А., Астахов Ю. С, Ставицкая Т. В. Офтальмофармакология. Руководство для врачей. - 3-е изд. - М.: Геотар-Медиа, 2009. - С. 120- 122.

2.Кирчанова О. В. Прогнозирование экссудативно-воспалительной реакции после факоэмульсификации катаракты на основе клинико-иммунологического мониторинга больных и способы ее коррекции: Авто-реферет дисс.... канд. мед. наук. - Воронеж, 2004. - 32 с.

3.Параконный Д. А. Сравнение эффективности, безопасности и экономичности двух схем медикаментозной терапии у пациентов после факоэмульсификации катаракты // Рефракционная хирургия и офтальмология. - 2010. - № 2. - С. 54- 56.

4.Хафизова Г. Ф. Оптимизация имплантации эластичных интраокулярных линз при ФЭК в зависимости от катаракты: Автореферат дисс канд. мед. наук. - М., 2008. - 26 с.

5.Barry P., Behrens-Baumann W., Pleyer U., Seal D. (Ed.). ESCRS Guidelines on prevention, investigation and management of post-operative endophtalmitis. Version 2. - 2007. - P. 14.

6.Notivol R., Amin D., Whitling A. et al. Prophylactic effectiveness of tobramycin-dexametasone eye drops compared with tobramycin/vehicle eye drops in controlling postsurgical inflammation in cataract patients // Clin. Drug. Invest. - 2004. - Vol. 24, N 9. - P. 523- 533.https://doi.org/10.2165/00044011-200424090-00003

Downloads

UKR (Ukrainian)

Published

2013-02-27

Issue

No. 1 (2013): Journal of Ophthalmology (Ukraine)

Section

Clinical Ophthalmology

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.

COPYRIGHT NOTICE

Authors who publish in this journal agree to the following terms:

Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
The copyright commencement date complies the publication date of the issue, where the article is included in.

DEPOSIT POLICY

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
Archiving the pre-print (pre-refereeing manuscript version) not allowed.